# medivation Agent Verification

## Run Metadata

- Slug: medivation
- Target: MEDIVATION INC
- Acquirer: PFIZER INC
- Run ID: `cef2a7af3cac41fbbd09c042df1ab1f5`
- Schema version: `deal_graph_v2`
- Rulebook version: `4a64eef546b7a8496600186879e4878cd5ae62b5bfc0385b93623b790d4a46d8`
- Model: `gpt-5.5`
- Reasoning effort: `high`
- Generated: 2026-05-07T11:06:07.509140Z
- Filing URL: https://www.sec.gov/Archives/edgar/data/1011835/0001193125-16-696889-index.htm

Artifacts:
- Audit run: `output/audit/medivation/runs/cef2a7af3cac41fbbd09c042df1ab1f5`
- Manifest: `output/audit/medivation/runs/cef2a7af3cac41fbbd09c042df1ab1f5/manifest.json`
- Raw response: `output/audit/medivation/runs/cef2a7af3cac41fbbd09c042df1ab1f5/raw_response.json`
- Graph JSON: `output/audit/medivation/runs/cef2a7af3cac41fbbd09c042df1ab1f5/deal_graph_v2.json`
- DuckDB: `output/audit/medivation/runs/cef2a7af3cac41fbbd09c042df1ab1f5/deal_graph.duckdb`
- Portable extraction: `output/extractions/medivation.json`
- Review JSONL: `output/review_rows/medivation.jsonl`
- Review CSV: `output/review_csv/medivation.csv`

## Commands

- `python -m pipeline.run_pool --filter all --workers 3 --re-extract --release-targets`
- `python scripts/check_reference_verification.py --slugs medivation`

## Extraction And Flag Summary

- Review statuses: clean: 32
- Open review rows: 0
- Flag severities: none
- Actors: 12
- Events: 12
- Bids: 6
- Participation counts: 1
- Actor relations: 7
- Evidence spans: 22
- Review rows: 32

## Filing-Grounded Calibration Ledger

| Item | Filing evidence | Decision |
|---|---|---|
| Current graph | Filing page evidence is bound through `evidence_refs` and Python-owned source spans for run `cef2a7af3cac41fbbd09c042df1ab1f5`. | SEC filing text controls the report; Alex calibration material is not an oracle. |
| Current review rows | Review status counts are clean: 32. | Rows are accepted only through exact source binding in the current artifact set. |
| Bidder class contract | Actor claims classify only `financial`, `strategic`, `mixed`, or `unknown`; U.S./non-U.S. and public/private details are out of scope. | This verification covers the restored minimal bidder-class contract. |

## Filing Evidence Review

The current artifact set was checked against the Background filing pages. The mechanical checker re-reads raw provider evidence refs, graph evidence spans, and review-row source quotes from the JSON artifacts and confirms exact filing-page grounding.

| Filing page | Claim type | Review status | Evidence excerpt |
|---|---|---|---|
| Filing page 25 | 25 | actor_claim | clean | Centerview Partners LLC (“Centerview”), a financial advisor to Pfizer / Centerview Partners LLC (“Centerview”), a financial advisor to Pfizer |
| Filing page 26 | 26 | actor_claim | clean | Cooley LLP (“Cooley”), a legal advisor to Medivation / Cooley LLP (“Cooley”), a legal advisor to Medivation |
| Filing page 25 | 25 | actor_claim | clean | Evercore Group L.L.C. (“Evercore”) / J.P. Morgan Securities LLC (“J.P. Morgan”) and Evercore Group L.L.C. (“Evercore”), financial advisors to Medivation |
| Filing page 25 | 25 | actor_claim | clean | Guggenheim Securities, LLC (“Guggenheim”), a financial advisor to Pfizer / Guggenheim Securities, LLC (“Guggenheim”), a financial advisor to Pfizer |
| Filing page 25 | 25 | actor_claim | clean | J.P. Morgan Securities LLC (“J.P. Morgan”) / J.P. Morgan Securities LLC (“J.P. Morgan”) and Evercore Group L.L.C. (“Evercore”), financial advisors to Medivation |
| Filing page 25 | 25 | 26 | 27 | actor_claim | clean | J.P. Morgan Securities LLC (“J.P. Morgan”) and Evercore Group L.L.C. (“Evercore”), financial advisors to Medivation / J.P. Morgan Securities LLC (“J.P. Morgan”) |
| Filing page 24 | 25 | 25 | 26 | 25 | 25 | 26 | 26 | 27 | 26 | 27 | 27 | actor_claim | clean | Pfizer identified Medivation as a potential opportunity for a strategic transaction / Centerview Partners LLC (“Centerview”), a financial advisor to Pfizer / Gu |
| Filing page 27 | event_claim | clean | Pfizer, Purchaser and Medivation each executed the Merger Agreement on the afternoon of Saturday, August 20, 2016. |
| Filing page 26 | 26 | actor_claim | clean | Pfizer’s outside counsel Ropes & Gray LLP (“Ropes & Gray”) / Pfizer’s outside counsel Ropes & Gray LLP (“Ropes & Gray”) |
| Filing page 24 | 25 | 25 | 24 | actor_claim | clean | from the Chief Executive Officer of Sanofi, setting forth a non-binding proposal / Sanofi’s proposal was publicly announced on April 28, 2016 and unanimously re |

## Contract Updates

This report cites the current `deal_graph_v2` run and the live artifact contract. Only the artifact paths listed above are verification authorities.

## Conclusion

Conclusion: VERIFIED
